Able to crush their Q4 bottom-line expectations on Thursday, Alaska Air Group (ALK) and The Travelers Companies (TRV) are two intriguing stocks to...

When Merck reports fourth-quarter earnings, investors are likely to focus on the sales of its blockbuster oncology medicine, Keytruda.

When MRNA reports fourth-quarter earnings, investors will likely focus on pipeline updates.

AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business impact of the Chinese...

Investors' focus will likely be on GILD's HIV franchise performance and oncology sales when the company reports fourth-quarter 2024 results.

Canadian National Railway reported lower earnings for the fourth quarter of 2024, citing supply chain disruptions and higher operating expenses, but...

CONMED reports solid fourth-quarter results, fueled by strength in the General Surgery segment and continued demand for AirSeal product.

MPWR reports top-line growth year over year in the fourth quarter of 2024 owing to healthy demand in several end markets.

CALHOUN, Ga., Feb. 06, 2025 (GLOBE NEWSWIRE) — Mohawk Industries, Inc. (NYSE: MHK) today announced fourth quarter 2024 net earnings of $93...

On CRSP's fourth-quarter 2024 earnings call, investors' focus will likely be on the sales figure of Casgevy, its first marketed product.